EYPT vs RHI · rev $1.2M vs P/E 21, rev $5.38B
Eyepoint Pharmaceuticals Inc (EYPT) versus Robert Half International Inc (RHI) — a side-by-side from cached financials, not a winner call.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
EYPT currently screens at market cap $1.10B. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Not investment advice. Open the EYPT and RHI stock pages for the full models.
Not investment advice.